-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D6SJ+O57dpaaotfxc1eRPQqphWgTx1aQDBJaH+Nodr+px3Z6AfTptTYd6AhEsEON Sk5crlsORivdGsh4Y6H6Yw== 0001104659-04-005959.txt : 20040227 0001104659-04-005959.hdr.sgml : 20040227 20040227164916 ACCESSION NUMBER: 0001104659-04-005959 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030328 FILED AS OF DATE: 20040227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PENDERGAST DAVID D PHD CENTRAL INDEX KEY: 0001236370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21481 FILM NUMBER: 04635982 MAIL ADDRESS: STREET 1: C/O TRANSKARYOTIC THERAPIES INC STREET 2: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173490200 4 1 a4.xml 4 X0201 4 2003-03-28 0 0000885259 TRANSKARYOTIC THERAPIES INC TKTX 0001236370 PENDERGAST DAVID D PHD 700 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Senior VP Manufacturing Stock Option (right to buy) 5.84 2003-03-28 4 A 0 25000 0 A 2013-03-28 Common Stock 25000 25000 D Stock Option (right to buy) 9.76 2003-06-11 4 A 0 33000 0 A 2013-06-11 Common Stock 33000 33000 D Stock Option (right to buy) 12.14 2004-02-25 4 A 0 45000 0 A 2014-02-25 Common Stock 45000 45000 D The option becomes exercisable in four equal semi-annual installments beginning on September 28, 2003. The option becomes exercisable in four equal semi-annual installments beginning on December 11, 2003. The option becomes exercisable in four equal annual installments beginning on February 25, 2005. /s/David D. Pendergast 2004-02-26 -----END PRIVACY-ENHANCED MESSAGE-----